Comparing ranibizumab @ mg versus sham or PTD treatment , respectively : @ % versus @ % and @ % versus @ % had maximum preinjection IOPs of @ mmHg or more or @ mmHg or more , respectively ; @ % versus @ % and @ % versus @ % had IOP increases from baseline of @ mmHg or more or @ mmHg or more , respectively ; @ % versus @ % and @ % versus @ % had @ or more IOP increase from baseline of @ mmHg or more or @ mmHg or more , respectively , with a concurrent IOP of @ mmHg or more ; @ % versus @ % and @ % versus @ % had @ or more IOP increase from baseline of @ mmHg or more or @ mmHg or more , respectively , with a concurrent IOP of @ mmHg or more .